Detalles de la búsqueda
1.
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Blood
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805638
2.
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.
Blood
; 134(12): 951-959, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292112
3.
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.
Blood
; 121(11): 1935-43, 2013 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319575
4.
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
Ann Hematol
; 94(8): 1347-56, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25975975
5.
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.
Cancers (Basel)
; 12(11)2020 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33120864
6.
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.
Sci Rep
; 10(1): 10315, 2020 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32587277
7.
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia.
Blood Adv
; 1(21): 1807-1814, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296827
8.
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).
Hematology
; 17 Suppl 1: S36-8, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22507775
9.
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Ann Hematol
; xx: [10 p.], mayo, 2015. tab
Artículo
en Inglés
| URUCAN | ID: bcc-4922
10.
Discriminação alélica do fator V da coagulação por PCR em tempo real: diagnóstico simples e preciso / Allelic discrimination of coagulation factor V by real time PCR: a simple and accurate diagnosis
Rev. bras. hematol. hemoter
; 31(1): 25-28, jan.-fev. 2009. ilus, graf
Artículo
en Portugués
| LILACS | ID: lil-511175
11.
Freqüência do fator V Leiden em indivíduos sob investigação de trombofilia, Recife, Pernambuco, Brasil / Frequency of factor V Leiden in individuals under thrombophilia investigation, Recife, Pernambuco, Brazil
Rev. bras. hematol. hemoter
; 28(2): 131-134, abr.-jun. 2006. tab
Artículo
en Portugués
| LILACS | ID: lil-446040
12.
Alta frequência de fatores de alto risco e de mortalidade precoce em pacientes brasileiros com leucemia promielocítica aguda / Increased frequency of high risk factors and elevated early mortality among Brazilian patients with acute promyelocytic leukemia
Rev. bras. hematol. hemoter
; 29(1,supl.1): 24-27, 2007. tab, graf
Artículo
en Inglés
| LILACS | ID: lil-537339
Resultados
1 -
12
de 12
1
Próxima >
>>